General Information of This Metabolic Reaction (MR) (ID:
MR009685) |
Formula |
|
Reactant |
Balsalazide |
Product |
5-aminosalicylic acid |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Quinone reductase 1 (NQO1)
|
DME Info
|
Metabolic Type
|
Unclear
-
Unclear
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
U. S. FDA Label -Balsalazide
|
2 |
Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease. Drugs. 1991 Apr;41(4):647-64.
|
3 |
Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population. Clin Chim Acta. 2009 Sep;407(1-2):30-5.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.